Company news
Spago Nanomedical AB news in 2026
Spago Nanomedical AB's news releases, calls and decks from 2026, newest first.
Notice Of Extraordinary General Meeting in Spago Nanomedical AB (PUBL)
September 21, 2026
Spago Nanomedical Interim Report January-June 2026
August 20, 2026
Bulletin from the 2026 Annual General Meeting of Spago Nanomedical AB
June 10, 2026
The subscription period in Spago Nanomedical’s rights issue begins today
June 3, 2026
Spago Nanomedical publishes information document in connection with forthcoming rights issue
June 2, 2026
Spago Nanomedical: Raises capital
May 22, 2026
Spago Nanomedical resolves on a rights issue of approximately SEK 16 million
May 22, 2026
Spago Nanomedical's Phase I/IIa study Tumorad-01 Meets a Primary Endpoint and Provides Further Visible Tumor Uptake
May 6, 2026
Spago Nanomedical's Abstract on Tumorad(R) Accepted for Presentation at Radiopharma Conference
March 24, 2026
Spago Nanomedical Continues Recruitment in The Phase I/IIa Tumorad-01 Study Following Positive DMC Recommendation
March 17, 2026
Spago Nanomedical Strengthens CMC and Supply Capabilities to Support Next Phase of Tumorad Development
March 10, 2026
Spago Nanomedical Year-End Report January-December, 2025
February 5, 2026